lonidamine has been researched along with Melanoma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glickson, JD; Lee, SC; Leeper, DB; Nath, K; Nelson, DS; Putt, ME; Roman, J | 1 |
| Feng, M; Glickson, J; Li, LZ; Lin, Z; Nath, K; Nelson, D; Roman, J; Xu, HN; Zhao, H | 1 |
| Coss, RA; Kulp, KA; Leeper, DB; Storck, CW; Wahl, M; Wells, TC | 1 |
| Glickson, JD; Heitjan, DF; Leeper, DB; Nath, K; Nelson, DS; Zhou, R | 1 |
| Blair, IA; Glickson, JD; Guo, L; Leeper, DB; Nath, K; Nelson, DS; Shestov, AA; Worth, AJ | 1 |
| Garman, B; Glickson, JD; Leeper, DB; Nath, K; Nathanson, KL; Nelson, DS; Putt, ME | 1 |
| Darpolor, MM; Glickson, JD; Heitjan, DF; Ho, AM; Lee, SC; Leeper, DB; Nath, K; Nelson, DS; Pickup, S; Zhou, R | 1 |
| Konovalova, NP | 1 |
| Ando, K; Miyato, Y | 1 |
| Aloe, L; Calabro, A; Carlini, S; Cavaliere, R; Di Filippo, F; Piarulli, L; Varanese, A | 1 |
| Battelli, T; Bellocci, M; Cavaliere, R; De Martino, C; Di Filippo, F; Gallo Curcio, C; Giustini, L; Manocchi, D; Mattioli, R; Rinaldi, M | 1 |
| Arancia, G; Calcabrini, A; Citro, G; Meschini, S; Molinari, A | 1 |
| Danjoux, CE; DeSanctis, AJ; Feeley, MM; Fisher, B; Maroun, J; Martin, L; Raaphorst, GP | 1 |
| Badaracco, G; Bertuzzi, A; Gandolfi, A; Greco, C; Starace, G; Totaro, MD; Vitelli, R; Zupi, G | 1 |
| Caputo, A; Delpino, A; Ferrini, U; Floridi, A; Marcante, ML; Nista, A; Silvestrini, B | 1 |
| Caputo, A; Delpino, A; Feriozzi, R; Floridi, A; Marcante, ML; Nista, A; Silvestrini, B | 1 |
16 other study(ies) available for lonidamine and Melanoma
| Article | Year |
|---|---|
Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Heterografts; Humans; Indazoles; Melanoma; Mice; Mice, Nude; Temozolomide; Transplantation, Heterologous | 2017 |
Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts.
Topics: Animals; Cell Line, Tumor; Electron Transport; Heterografts; Humans; Indazoles; Melanoma; Mice, Nude; Mitochondria; Mitochondrial Uncoupling Proteins; Optical Imaging; Oxidation-Reduction | 2019 |
Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH.
Topics: Cell Line, Tumor; Cell Survival; Heat-Shock Proteins; Hot Temperature; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Hydrogen-Ion Concentration; Indazoles; Melanoma; Molecular Chaperones; Monocarboxylic Acid Transporters; Radiation-Sensitizing Agents | 2014 |
Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.
Topics: Acids; Animals; Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Hyperglycemia; Indazoles; Intracellular Space; Magnetic Resonance Spectroscopy; Male; Melanoma; Melphalan; Mice, Nude; Organ Specificity; Xenograft Model Antitumor Assays | 2015 |
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Citric Acid Cycle; Diacetyl; Electron Transport Complex II; Fumarates; Glutamine; Glutathione; Humans; Indazoles; Malates; Melanoma; Metabolic Flux Analysis; Mitochondria; Models, Biological; NADP; Naphthalenes; Oxidation-Reduction; Pentose Phosphate Pathway; Reactive Oxygen Species; Succinic Acid | 2016 |
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Synergism; Humans; Indazoles; Male; Mechlorethamine; Melanoma; Melphalan; Mice; Mice, Nude; Mice, SCID; Xenograft Model Antitumor Assays | 2016 |
(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Drug Synergism; Energy Metabolism; Hydrogen-Ion Concentration; Indazoles; Magnetic Resonance Spectroscopy; Melanoma; Melphalan; Mice; Phosphorus Radioisotopes; Protons; Treatment Outcome | 2013 |
Ultralow doses of various drugs in chemotherapy of experimental tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Indazoles; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Mitomycin; Neoplasm Metastasis; Neoplasms, Experimental; Triazoles; Xenograft Model Antitumor Assays | 2003 |
Apoptosis of human melanoma cells by a combination of lonidamine and radiation.
Topics: Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; Carrier Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Melanoma; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Suppressor Protein p53; X-Rays | 2004 |
Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.
Topics: Administration, Oral; Antineoplastic Agents; Humans; Hyperthermia, Induced; Indazoles; Injections, Intra-Arterial; Melanoma; Melphalan; Pyrazoles | 1984 |
Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Humans; Hyperthermia, Induced; Indazoles; Melanoma; Mice; Neoplasms; Pyrazoles; Skin Neoplasms | 1984 |
Intracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy study.
Topics: Breast Neoplasms; Cell Nucleus; Cytoplasm; Doxorubicin; Drug Resistance, Multiple; Fluorescence; Humans; Indazoles; Melanoma; Microscopy, Confocal; Tumor Cells, Cultured; Verapamil | 1994 |
The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Survival; Cricetinae; Fibroblasts; Glioma; Humans; Hyperthermia, Induced; Indazoles; Melanoma; Mice; Neoplasms; Radiotherapy; Tumor Cells, Cultured | 1991 |
Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Division; Cell Line; Cell Survival; Doxorubicin; Humans; Hyperthermia, Induced; Indazoles; Melanoma; Pyrazoles | 1987 |
Induction of stress proteins by lonidamine in human and murine melanoma cells.
Topics: Animals; Cell Line; Electrophoresis, Polyacrylamide Gel; Energy Metabolism; Heat-Shock Proteins; Humans; Indazoles; Melanoma; Mice; Mitochondria; Neoplasm Proteins; Pyrazoles | 1986 |
Effect of lonidamine on protein synthesis in neoplastic cells.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line; Cell-Free System; Dinitrobenzenes; Glycolysis; Humans; Indazoles; Kinetics; Lactates; Leukemia, Experimental; Male; Melanoma; Mice; Neoplasm Proteins; Oligomycins; Pyrazoles; Rabbits; Sarcoma, Experimental | 1985 |